VERTEX PHARMACEUTICALS SCHEDULE 13G

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

January 11, 2006

Accession Number

0001160550-06-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →